Watson PJ, Herrtage ME. Medical management of congenital portosystemic shunts in 27 dogs—retrospective study. J Small Anim Pract 1998;39:62–68.
Hottinger HA, Walshaw R, Hauptman JG. Long term results of complete and partial ligation of congenital portosystemic shunts in dogs. Vet Surg 1995;24:331–336.
Lawrence D, Bellah JR, Diaz R. Results of surgical management of portosystemic shunts in dogs: 20 cases (1985–1990). J Am Vet Med Assoc 1992;201:1750–1753.
Kummeling A, Van Sluijs FJ, Rothuizen J. Prognostic implications of the degree of shunt narrowing and of the portal vein diameter in dogs with congenital portosystemic shunts. Vet Surg 2004;33:17–24.
Swalec KM, Smeak DD. Partial versus complete attenuation of single portosystemic shunts. Vet Surg 1990;19:406–411.
Komtebedde J, Koblik PD, Breznock EM, et al. Long term clinical outcome after partial ligation of single extrahepatic vascular anomalies in 20 dogs. Vet Surg 1995;24:379–383.
Havig M, Tobias KM. Outcome of ameroid constrictor occlusion of single congenital extrahepatic portosystemic shunts in cats: 12 cases (1993–2000). J Am Vet Med Assoc 2002;220:337–341.
Adin CA, Gregory CR, Kyles AE, et al. Effect of petrolatum coating on the rate of occlusion of ameroid constrictors in the peritoneal cavity. Vet Surg 2004;33:11–16.
Kyles AE, Hardie EM, Mehl M, et al. Evaluation of ameroid ring constrictors for the management of single extrahepatic portosystemic shunts in cats: 23 cases (1996–2001). J Am Vet Med Assoc 2002;220:1341–1347.
Kyles AE, Gregory CR, Jackson J, et al. Evaluation of a portocaval venograft and ameroid ring for the occlusion of intrahepatic portocaval shunts in dogs. Vet Surg 2001;30:161–169.
Murphy ST, Ellison GW, Long M, et al. A comparison of the Ameroid constrictor versus ligation in the surgical management of single extrahepatic portosystemic shunts. J Am Anim Hosp Assoc 2001;37:390–396.
Vogt JC, Krahwinkel DJJ, Bright RM, et al. Gradual occlusion of extrahepatic portosystemic shunts in dogs and cats using the ameroid constrictor. Vet Surg 1996;25:495–502.
Youmans KR, Hunt GB. Experimental evaluation of four methods of progressive venous attenuation in dogs. Vet Surg 1999;28:38–47.
Connery PNA, McAllister H, Skelly C, et al. Cellophane banding of congenital intrahepatic portosystemic shunts in two Irish wolfhounds. J Small Anim Pract 2002;43:345–349.
Harari J, Lincoln J, Alexander J, et al. Lateral thoracotomy and cellophane banding of a congenital portoazygous shunt in a dog. J Small Anim Pract 1990;31:571–573.
Hunt GB, Hughes J. Outcomes after extrahepatic portosystemic shunt ligation in 49 dogs. Aust Vet J 1999;77:303–307.
Hunt GB, Kummeling A, Tisdall PL, et al. Outcomes of cellophane banding for congenital portosystemic shunts in 106 dogs and 5 cats. Vet Surg 2004;33:25–31.
Youmans KR, Hunt GB. Cellophane banding for the gradual attenuation of single extrahepatic portosystemic shunts in eleven dogs. Aust Vet J 1998;76:531–537.
Besancon MF, Kyles AE, Griffey SM, et al. Evaluation of the characteristics of venous occlusion after placement of an ameroid constrictor in dogs. Vet Surg 2004;33:597–605.
Birchard SJ. Surgical management of portosystemic shunts in dogs and cats. Compend Contin Educ Pract Vet 1984;6:795–801.
Johnson CA, Armstrong PJ, Hauptman JG. Congenital portosystemic shunts in dogs: 46 cases (1979–1986). J Am Vet Med Assoc 1987;191:1478–1483.
Holt DE, Schelling CG, Saunders HM, et al. Correlation of ultrasonographic findings with surgical, portographic, and necropsy findings in dogs and cats with portosystemic shunts: 63 cases (1987–1993). J Am Vet Med Assoc 1995;207:1190–1193.
Samii VF, Kyles AE, Long CD, et al. Evaluation of interoperator variance in shunt fraction calculation after transcolonic scintigraphy for diagnosis of portosystemic shunts in dogs and cats. J Am Vet Med Assoc 2001;218:1116–1119.
Van Vechten BJ, Komtebedde J, Koblik PD. Use of transcolonic portal scintigraphy to monitor blood flow and progressive postoperative attenuation of partially ligated single extrahepatic portosystemic shunts in dog. J Am Vet Med Assoc 1994;204:1770–1774.
Center SA, Baldwin BH, Delahunta A, et al. Evaluation of serum bile acid concentrations for the diagnosis of portosystemic venous anomalies in the dog and cat. J Am Vet Med Assoc 1985;186:1090–1094.
Burton CA, White RN. Portovenogram findings in cases of elevated bile acid concentrations following correction of portosystemic shunts. J Small Anim Pract 2001;42:536–540.
Martin RAE. Portosystemic shunts. Semin Vet Med Surg (Small Anim) 1990;5:75–141.
Martin RA, Freeman LE. Identification and surgical management of portosystemic shunts in the dog and cat. Semin Vet Med Surg (Small Anim) 1987;2:302–306.
Birchard SJ, Biller DS, Johnson SE. Differentiation of intrahepatic versus extrahepatic portosystemic shunts in dogs using positive-contrast portography. J Am Anim Hosp Assoc 1989;25:13–17.
Daniel GB, Bright R, Monnet E, et al. Comparison of per rectal portal scintigraphy using 99m Technetium pertechnate to mesenteric injection of radioactive microspheres for quantification of portosystemic shunts in an experimental dog model. Vet Radiol 1990;31:175–181.
Daniel GB, Bright R, Ollis P, et al. Per rectal portal scintigraphy using 99m-technetium pertechnetate to diagnose portosystemic shunts in dogs and cats. J Vet Intern Med 1991;5:23–27.
MacPhail CM, Monnet E, Gaynor JS. Evaluation of splanchnic oxygen extraction ratio as an index of portal vein pressure in dogs. Am J Vet Res 2002;63:15–18.
Papazoglou LG, Monnet E, Seim HB III. Survival and prognostic indicators for dogs with intrahepatic portosystemic shunts: 32 cases (1990–2000). Vet Surg 2002;31:561–570.
Advertisement
Objective—To evaluate the effect of intraoperative attenuation of congenital extrahepatic portosystemic shunts (CEPSSs) during cellophane banding procedures in dogs.
Study Design—Retrospective case series and prospective study.
Animals—18 cases evaluated retrospectively and 14 dogs evaluated prospectively.
Procedures—Gradual occlusion of CEPSSs was performed via cellophane banding. Shunts were occluded to a diameter < 3.0 mm during surgery in dogs prospectively enrolled in the partial attenuation group, whereas the shunt was not attenuated during surgery in dogs prospectively enrolled in the no-attenuation group or in dogs that had previously undergone surgery and were retrospectively evaluated. Postprandial serum bile acids (PPSBA) concentrations were measured before surgery and at various time points after surgery.
Results—Mean ± SD PPSBA concentrations were 26.8 ± 24.5 μmol/L at < 2.25 months after surgery (n = 16 dogs), 22.1 ± 14.0 μmol/L from 2.25 to 6 months after surgery (12 dogs), and 34.9 ± 32.5 μmol/L at > 6 months after surgery (22 dogs). In the prospectively enrolled dogs, mean PPSBA concentrations increased over time in dogs in the partial attenuation group, but not in dogs in the no-attenuation group.
Conclusions and Clinical Relevance—Cellophane banding may be used to occlude larger CEPSSs and may decrease the need for intraoperative monitoring of portal vein blood pressure. The technique may facilitate minimally invasive treatment of CEPSSs in dogs. Intraoperative attenuation of CEPSSs to a diameter < 3.0 mm is not necessary and may result in a less favorable outcome.